INAHTA represented at MENA Second Regional Health Technology Assessment Policy Forum
Dr. Sophie Söderholm Werkö, INAHTA Board Chair, Dr. Mouna Jameleddine, INAHTA Board Director, and Dr Iñaki Gutiérrez-Ibarluzea (Osteba) participated in panel discussions at the Second Regional Health Technology Assessment Policy Forum in Dubai on 17-18 September 2018.
7th ISPOR South Africa Chapter Conference to be held 17-18 September 2018 in Johannesburg, SA
Topic: Universal Access to Health: The Role of HTA and HEOR
19-21 February 2019
Evaluation of Medical Devices for Product Development and Health Technology Assessment
This 3-day course offered by the York Health Economics Consortium (YHEC) and the Department of Health Sciences and the Centre for Health Economics, UK provides a comprehensive overview of key issues associated with medical devices clinical and economic evaluation and the creative alternative methods available to robustly evaluate them. It is aimed at medical device developers, manufacturers, regulators, healthcare practitioners, analysts, consultants, and health technology assessors interested in optimising the evidence generation processes aimed at informing key decisions they are faced with throughout the full development and evaluation pathway of medical devices.
For more information on course content or how to book, please visit:
INAHTA is pleased to welcome the Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) as a full member of INAHTA.
The objective of FinCCHTA is to coordinate HTA in Finland as well as to cooperate with international HTA bodies. Other key objectives are to develop HTA methodological training and strengthen its related research.
INAHTA is proud to have world-class leaders in HTA as members of the INAHTA Board.
This year, we welcome a number of new Board members:
Chair: Sophie Söderholm Werkö, SBU, Sweden
Vice Chair: Tracy Merlin, AHTA, Australia
Three new Directors:
Mouna Jameleddine, INASanté, Tunisia;
Michelle Mujoomdar, CADTH, Canada
Matthias Perleth, G-BA, Germany
These new Board members join Mrs. Debjani (Jani) Mueller, who continues her term as Director to June 2019.
View Board member profiles
INAHTA will have a exhibitor booth at the HTAi Annual Meeting from 1-5 June 2018 (visit conference website).
Come visit us at booth #3 at the beautiful conference venue, the Westin Bayshore, Vancouver, Canada.
INAHTA members are invited to view video recordings of two recent webinars presenting the results of a survey of hot topics in HTA. This survey gathered views from member agencies about what key issues they face, what learning interests they have and what are some hot topics in their agency and region/country.
View webinar (login required)
On 9 May, 2018, the Utrecht Institute for Pharmaceutical Sciences is hosting an international symposium on the use of real-world evidence (RWE) in drug regulation and health technology assessment (HTA) in Utrecht, the Netherlands.
Registration for the Symposium is required: https://goo.gl/forms/8meSbj1C2ieGLEtz1
For more information:
IMI GetReal initiative is offering an interactive online course will give an understanding of current techniques, opportunities and challenges for the use of real-world evidence in medicine development.
The learning units will cover the following topics:
- Overview of the medicine development landscape
- Real-world evidence generation
- Real-world evidence synthesis
- Decision-making and weighing of evidence
- Demonstrating relative effectiveness to decision-makers
"Strengthening the Evidence-to-Action Connection" is the theme of the 2018 HTAi Annual Meeting to be held 1-5 June 2018 in beautiful Vancouver, Canada.
Join INAHTA members at this world-class event to share and learn with the global HTA community about:
- how HTA needs to change its approach to generating, synthesizing and presenting evidence in order to remain relevant in a rapidly changing world;
- what is required to enable the implementation of evidence into evidence-informed policies and practices, and
- what can be done to strengthen and accelerate the evidence-to-action connection.
Visit conference website for details.
Early bird registration deadline is 31 March 2018